Figure 1.

Development of transfection method for human endothelial cells. A, HEPC.CB1 EPC viability after luciferase plasmid delivery as determined by reducing potential; B, HEPC.CB1 EPC luciferase reporter expression; n = 3‐9 independent experiments. C, mature endothelial cell viability with protocol modification; D, mature endothelial cell luciferase reporter expression with protocol modification. RLU, relative luminescence units, n = 3. **P < .01; ***P < .001 statistical difference from control group. Mean ± SEM